title: Brodalumab and suicidal ideation in the context of a recent economic crisis in the United States.
authors.affiliation: University of California, San Francisco, School of Medicine, San Francisco, California.
authors.forename: Melissa J
authors.initials: MJ
authors.lastname: Danesh
authors.affiliation: Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: harvardskinstudies@partners.org.
authors.forename: Alexa B
authors.initials: AB
authors.lastname: Kimball
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000191:economics / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D017326:Clinical Trials, Phase III as Topic; D018592:Cross-Over Studies; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D057172:Economic Recession; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy* / Q000401:mortality / Q000523:psychology; D016032:Randomized Controlled Trials as Topic / Q000191:economics; D018570:Risk Assessment; D059020:Suicidal Ideation; D013405:Suicide / Q000523:psychology / Q000706:statistics & numerical data*; D014481:United States
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C571216:brodalumab
keywords: anti-IL-17RA; brodalumab; depression; economic recession; monoclonal antibody; suicidal ideation; suicide